SHAREHOLDER ALERT: WeissLaw LLP Investigates GigCapital2, Inc.

·2 min read

NEW YORK, Nov. 30, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GigCapital2, Inc. ("GIX" or the "Company") (NYSE: GIX) in connection with the Company's proposed merger with privately held digital healthcare provider UpHealth Holdings, Inc. ("UpHealth") and privately held telemedicine provider Cloudbreak Health, LLC ("Cloudbreak"). GIX will combine with UpHealth and Cloudbreak via a reverse-merger to create a single digital healthcare company to be named UpHealth, Inc. and will be listed on the NYSE under the new ticker symbol "UPH." The transaction values the combined company at a combined pro forma estimated enterprise value of approximately $1.35 billion.

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)
WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own GIX shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

Or please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771

WeissLaw is investigating whether GIX's board acted in the best interest of GIX's public shareholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of UpHealth and Cloudbreak, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to GIX public shareholders.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at


View original content to download multimedia: